These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8624755

  • 1. Examining the molecular genetics of HTLV-I with an infectious molecular clone of the virus and permissive cell culture systems.
    Derse D, Mikovits J, Waters D, Brining S, Ruscetti F.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May 01; 12(1):1-5. PubMed ID: 8624755
    [Abstract] [Full Text] [Related]

  • 2. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro.
    Derse D, Mikovits J, Ruscetti F.
    Virology; 1997 Oct 13; 237(1):123-8. PubMed ID: 9344914
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells.
    Derse D, Mikovits J, Polianova M, Felber BK, Ruscetti F.
    J Virol; 1995 Mar 13; 69(3):1907-12. PubMed ID: 7853532
    [Abstract] [Full Text] [Related]

  • 5. Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus.
    Nagata K, Tezuka K, Kuramitsu M, Fuchi N, Hasegawa Y, Hamaguchi I, Miura K.
    J Virol; 2024 Feb 20; 98(2):e0186223. PubMed ID: 38294250
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Construction of a full-length human T cell leukemia virus type I genome from MT-2 cells containing multiple defective proviruses using overlapping polymerase chain reaction.
    Ohsugi T, Kumasaka T, Urano T.
    Anal Biochem; 2004 Jun 15; 329(2):281-8. PubMed ID: 15158488
    [Abstract] [Full Text] [Related]

  • 8. Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes.
    Alais S, Mahieux R, Dutartre H.
    J Virol; 2015 Oct 15; 89(20):10580-90. PubMed ID: 26269171
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
    Hiraragi H, Kim SJ, Phipps AJ, Silic-Benussi M, Ciminale V, Ratner L, Green PL, Lairmore MD.
    J Virol; 2006 Apr 15; 80(7):3469-76. PubMed ID: 16537614
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
    Shuh M, Hill SA, Derse D.
    Virology; 1999 Sep 30; 262(2):442-51. PubMed ID: 10502522
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.
    Collins ND, Newbound GC, Albrecht B, Beard JL, Ratner L, Lairmore MD.
    Blood; 1998 Jun 15; 91(12):4701-7. PubMed ID: 9616168
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.
    Gabet AS, Mortreux F, Talarmin A, Plumelle Y, Leclercq I, Leroy A, Gessain A, Clity E, Joubert M, Wattel E.
    Oncogene; 2000 Oct 12; 19(43):4954-60. PubMed ID: 11042682
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.